• Mashup Score: 0

    October 3, 2023 — A discovery of a mutation in the gene ACTA2 has given researchers, led by Dianna Milewicz, MD, PhD, with UTHealth Houston, insight into understanding the cause of a rare and progressive problem with arteries in the brain and a cause of strokes in young children, called moyamoya disease.  The findings were published today in Nature Cardiovascular Research.  Moyamoya disease is a condition where the arteries going through the neck and into the brain become blocked right when the arteries enter the brain. Moyamoya disease can lead to strokes and seizures. Children only a few months old can suffer a stroke due to the disease. Current treatments are limited to medications to reduce the risk of stroke and surgery to open or bypass blocked arteries.  “This disease is one of the major causes of stroke in children and nobody knows why this happens or why these arteries get clogged,” said Milewicz, senior author of the study and professor and director of the Division of Medical

    Tweet Tweets with this article
    • @DAICeditor @DiannaMilewicz @UTHealthHouston A discovery of a mutation in the gene #ACTA2 has given researchers insight into understanding the cause of a rare and progressive problem with #arteries in the brain and a cause of #strokes in young #children: https://t.co/ScCWxejCDG

  • Mashup Score: 1

    Article courtesy of Dr. Joel Kahn, MD, who is a Clinical Professor of Medicine at Wayne State University School of Medicine, one of the world’s top cardiologists, a best-selling author, lecturer, and a leading expert in plant-based nutrition and holistic care.

    Tweet Tweets with this article
    • RT @WorldHealth_Net: https://t.co/8GVdiRTphX with @drjkahn #womenshealth #cardiovascular #hearthealth #heart #Atherosclerosis #arteries #f…

  • Mashup Score: 0

    May 12, 2023 — The US FDA has granted an Investigational Device Exemption (IDE) approval for Concept Medical Inc’s novel MagicTouch Sirolimus Coated Balloon (SCB) for the treatment of Small Vessels (SV) in coronary arteries.  US FDA, on the 25th of April 2023, granted the third IDE approval for Concept Medical’s Sirolimus Coated Balloon – MagicTouch SCB. Along with this latest IDE approval for…

    Tweet Tweets with this article
    • @DAICeditor @conceptmedicals The #FDA has granted an #InvestigationalDeviceExemption (#IDE) approval for Concept Medical Inc’s novel #MagicTouch #Sirolimus #CoatedBalloon (#SCB) for the treatment of Small Vessels (#SV) in #coronary #arteries: https://t.co/Z419EeI7AP

  • Mashup Score: 0

    Background: Multiple renal arteries (MRA) are often encountered during living-donor kidney transplantation (LDKT), requiring surgeons to pursue complex renovascular reconstructions prior to graft implantation. With improvements in reconstruction and anastomosis techniques, allografts with MRA can be successfully transplanted with similar outcomes to allografts with a single renal artery. Here, we…

    Tweet Tweets with this article
    • Complex reconstruction to create a single ostium for graft implantation if multiple #arteries are present during #living #donor #Kidneytransplant, shows acceptable ischemic time, with no increased risk of post operative vascular or urological complications https://t.co/yRRjeSEGhc https://t.co/AyTmBI10e6

  • Mashup Score: 0

    March 8, 2022 – MemorialCare Heart & Vascular Institute (MHVI), through its advanced research program, is participating in a CSL Behring-sponsored multi-center, Phase III clinical trial – “ApoA-I Event reducinG in Ischemic Syndromes II (AEGIS-II) – which is studying the removal of cholesterol from the arteries to reduce the risk of a second heart attack or stroke in patients. All three adult…

    Tweet Tweets with this article
    • @DAICeditor #MHVI is participating in a #CSL Behring-sponsored multi-center, Phase III clinical trial #AEGIS_II, which is studying the removal of #cholesterol from the #arteries to reduce the risk of a second #heartattack or #stroke in patients: https://t.co/ZCvZbkp5In